What are BioCryst Pharmaceuticals's profit margins?

BioCryst Pharmaceuticals (BCRX) runs a 97.8% gross margin and a -43.1% operating margin, with a -51.7% net margin.

Where do BioCryst Pharmaceuticals's ratios come from?

Every ratio is computed from BioCryst Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

BioCryst Pharmaceuticals BCRX Ratios & Valuation

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Gross margin	97.8%-0.1pp	97.8%+0.4pp	97.4%+0.4pp	97%+0.1pp	96.9%-0.4pp
Operating margin	-43.1%-82.1pp	39%+26.3pp	12.7%+3.0pp	9.7%+3.1pp	6.6%+7.2pp
Net margin	-51.7%-81.9pp	30.2%+31.6pp	-1.5%+4.9pp	-6.4%+4.2pp	-10.6%+9.1pp
EBITDA margin	-42.9%-82.0pp	39.1%+26.2pp	12.9%+3.0pp	10%+3.1pp	6.8%+7.1pp
Free cash flow margin	35%-4.4pp	39.4%+31.4pp	8%—	——	——
Returns
Return on assets	-96.9%-149pp	52.5%+54.4pp	-1.9%+5.8pp	-7.7%+3.6pp	-11.3%+6.4pp
Efficiency
Asset turnover	1.9×+0.1×	1.7×+0.5×	1.3×+0.1×	1.2×+0.1×	1.1×+0.2×
Inventory turnover	0.7×-0.1×	0.8×+0.1×	0.7×0.0×	0.7×+0.2×	0.6×—
Liquidity
Current ratio	1.9×-0.2×	2.1×+0.2×	1.9×-0.4×	2.2×-0.7×	2.9×+0.3×
Quick ratio	1.8×-0.2×	1.9×+0.2×	1.7×-0.4×	2.1×-0.6×	2.8×+0.3×
Cash ratio	0.9×+0.4×	0.5×0.0×	0.4×-0.1×	0.5×-0.3×	0.8×+0.1×
Leverage
Debt-to-assets	0.9×+0.9×	0×-0.4×	0.5×-0.1×	0.6×-0.1×	0.7×0.0×
Interest coverage	-5.1×-9.4×	4.3×+3.5×	0.9×+0.3×	0.6×+0.2×	0.3×+0.4×
Per Share
Book value per share	-$2.29-319%	-$0.55+69.1%	-$1.76+8.0%	-$1.92+8.7%	-$2.10+8.8%
Valuation
Market capitalization	$2.39B+45.3%	$1.64B+3.2%	$1.59B-23.3%	$2.08B+32.6%	$1.57B+0.6%
Enterprise value	$2.63B+67.8%	$1.57B-8.8%	$1.72B-23.6%	$2.25B+25.5%	$1.79B+0.5%
Price / sales	2.7×+0.8×	1.9×-0.8×	2.7×-1.1×	3.7×+0.6×	3.1×-0.3×
EV / sales	3×+1.2×	1.8×-1.1×	2.9×-1.2×	4×+0.5×	3.6×-0.4×
Free cash flow yield	13%-8.0pp	21%+18.0pp	3%—	——	——
Earnings yield	-19.2%-35.2pp	16.1%+16.6pp	-0.6%+1.2pp	-1.7%+1.7pp	-3.4%+2.3pp

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about BioCryst Pharmaceuticals.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What are BioCryst Pharmaceuticals's profit margins?: BioCryst Pharmaceuticals (BCRX) runs a 97.8% gross margin and a -43.1% operating margin, with a -51.7% net margin.
Where do BioCryst Pharmaceuticals's ratios come from?: Every ratio is computed from BioCryst Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.